Stealth’s lead investigational compound elamipretide targets the inner mitochondrial membrane, binds to cardiolipin and …
LC-Fatty Acid Oxidation Disorders: Recent Updates on the REN001 Study
There was much discussion about current research in FAODs at the 2022 International Metabolic conference. Reneo …
MELAS Spectrum Disorders and Sonlicromanol: Progress Update
Join MitoAction and Dr. Jan Smeitink, CEO of Khondrion for our our March Expert Series presentation. MELAS spectrum …
The Mito Disease Drug Development Journey
Join Dr. Matt Klein from PTC Therapeutics , MitoAction and Cure Mito for an exclusive webinar discussing the history of …
Moving Mito Medicine: Reneo Strides Study
On Friday, June 4 at 12:00pm EST, we will be joined by Dr. Madhu Davies from Reneo Pharmaceuticals for …
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 6
- Next Page »
